✓ verbatim from the press ? no verbatim passage
The Ministry of Health began on Saturday (20) the application of the 20-valent pneumococcal vaccine (VPC20), known as pneumo 20, in children under 5 years old. The immunizer replaces the 10-valent pneumococcal vaccine (VPC10) and protects against 20 serotypes of the Streptococcus pneumoniae bacteria, the main cause of serious diseases such as pneumonia and meningitis. According to Health Minister Alexandre Padilha, in addition to children up to 5 years old, the vaccine will be available in SUS for bedridden elderly and elderly who have chronic pneumopathy and chronic pulmonary disease. The Ministry's estimate is to immunize around 2 million children across the country. ✓
Press quotes (3)
"O Ministério da Saúde iniciou neste sábado (20) a aplicação da vacina pneumocócica 20-valente (VPC20), conhecida como pneumo 20, em crianças menores de 5 anos."
"Além das crianças de até 5 anos, essa vacina vai estar disponível no SUS para os idosos acamados e idosos que têm pneumopatia crônica, e doença pulmonar crônica"
"A estimativa do Ministério da Saúde é de imunizar cerca de 2 milhões de crianças em todo o país."
The decision to incorporate pneumo 20 was formalized by SCTIE/MS Ordinance No. 6, which followed a recommendation from Conitec — the National Commission for Incorporation of Technologies in SUS. Anvisa approved Prevenar 20 (trade name of the vaccine manufactured by Pfizer) on August 28, 2025, with indication for prevention of invasive disease, pneumonia and acute otitis media caused by 20 serotypes of Streptococcus pneumoniae in infants, children and adolescents between 6 weeks and less than 18 years. Conitec cited serotypes 3, 6A and 19A as the primary focus of introduction, as they are the ones that most cause invasive pneumococcal disease in children up to five years of age. ?
Press quotes (4)
"O Comitê de Medicamentos da Conitec recomendou a incorporação das vacinas pneumocócicas conjugadas para imunização de crianças até 5 anos de idade contra doença pneumocócica, conforme estratégia a ser definida pelo Programa Nacional de Imunizações. Decisão final: PORTARIA SCTIE/MS Nº 6"
"Indicação em bula aprovada pela Agência Nacional de Vigilância Sanitária (Anvisa) em 28/08/2025 (Prevenar® 20): Prevenção de doença invasiva, pneumonia e otite média aguda causadas por Streptococcus pneumoniae dos sorotipos 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F e 33F em bebês, crianças e adolescentes com idade entre 6 semanas e menos de 18 anos de idade."
"Indicação proposta pelo demandante para avaliação da Conitec: Prevenção da doença pneumocócica invasiva e pneumonia provocada pelos sorotipos 3, 6A e 19A, em crianças de até cinco anos de idade."
"A vacina Pneumo 20 Conjugada ( Prevenar 20)é a nova ... This is the schedule that Pfizer itself, the manufacturer of the vaccine"
The differential of the new vaccine, according to the Ministry of Health, is the expansion of immunological protection against serotypes that most cause invasive pneumonia, especially types 3, 6A and 19A, being more comprehensive than the previous 10-serotype formulation. The vaccine also acts against otitis media, a condition that can lead to hearing loss and generalized infection. Between 2023 and 2025, Brazil registered 4.6 thousand cases of pneumococcal meningitis and 1.4 thousand deaths, representing a fatality rate exceeding 30%. Among children under 5 years old, there were 616 cases and 188 deaths in the same period. ✓
Press quotes (2)
"o diferencial da nova vacina é a ampliação da proteção imunológica, relacionada aos sorotipos que mais causam pneumonia invasiva, especialmente os tipos 3, 6A e 19A, sendo mais abrangente do que as formulações anteriores"
"No Brasil, entre 2023 e 2025, foram registrados 4,6 mil casos de meningite pneumocócica e 1,4 mil óbitos, o que representa uma taxa de letalidade superior a 30%. Entre crianças menores de 5 anos, foram 616 casos e 188 mortes no mesmo período."
SUS acquired more than 8 million doses of pneumo 20. Distribution of the first 514 thousand doses has already begun, and the Ministry of Health's forecast is to make available more than 6.1 million doses still in 2026. The event that marked the beginning of vaccination took place in the South Zone of São Paulo, at AMA/Integrated Basic Health Unit Vila Prel, in the Campo Limpo region. In the capital of São Paulo, the vaccine will be available at AMAs/Integrated UBSs until 7 pm this Saturday; from Monday (22), application will be expanded to all UBSs in the capital. ✓
Press quotes (3)
"A distribuição das primeiras 514 mil doses já começou... A previsão do Ministério da Saúde é disponibilizar mais de 6,1 milhões de doses ainda este ano."
"O SUS adquiriu mais de 8 milhões de doses"
"O evento que marcou o início da vacinação com a pneumo 20 ocorreu na Zona Sul de São Paulo, na AMA/Unidade Básica de Saúde (UBS) Integrada Vila Prel, na região do Campo Limpo."
The pneumo 20 vaccine replaces the 10-valent pneumococcal vaccine (VPC10) that protected against ten serotypes of the Streptococcus pneumoniae bacteria
Vaccination began in São Paulo at AMA/Integrated UBS Vila Prel, Campo Limpo region, on Saturday June 20, 2026
Between 2023 and 2025, Brazil registered 4.6 thousand cases of pneumococcal meningitis and 1.4 thousand deaths, with a fatality rate exceeding 30%
Covered by only some sources, or where the accounts diverge.
Covered by only some sources (2)
Pfizer is the manufacturer of the pneumo 20 vaccine (brand name Prevenar 20) supplied to SUS
Serotypes 3, 6A and 19A were cited by Conitec as the primary focus for pneumo 20 introduction, as they most cause invasive pneumococcal disease in children up to five years
-
What is the unit price paid by SUS per dose of pneumo 20, the duration of the supply contract with Pfizer, and any revision clauses?
Why it's still unknown: Contract acquisition details (unit price, duration, revision clauses) were not found in consulted public sources. Searches on government procurement websites and Planejamento.gov.br did not return public contract documents with these details.
-
Is there participation of Bio-Manguinhos or another Brazilian institution in domestic production of pneumo 20, or is the entire supply imported?
Why it's still unknown: Press coverage and Conitec documents do not specify whether there is national production technology involved or if the supply is entirely imported from Pfizer.